For U.S. patients with severe hemophilia A, prophylaxis with efanesoctocog alfa is neither conventionally nor ...

Hemophilia is a rare, inherited bleeding disorder in which the blood does not clot normally due to a deficiency in essential ...

The World Federation of Hemophilia (WFH) and WFH USA, together with Sanofi, through its philanthropic organization Foundation ...

Haemophilia patients at GMC Srinagar’s day care centre on Thursday said life saving clotting drugs remain unavailable, ...

McElya, senior director, clinical pharmacy at Walgreens, notes that approximately half of the drugs approved by the FDA last year were first-in-class drugs.

Australia: In a significant development for Hemophilia B treatment, a multi-year follow-up study has shown that a single ...

Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial assistanceSTOCKHOLM, April 25, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) together ...

We partner with governments and hemophilia treatment centres to enhance knowledge through training and provide tools they need to identify, support and treat people living with bleeding disorders ...

Sobi® (STO: SOBI) together with the World Federation of Hemophilia (WFH) and Sanofi, through its philanthropic organisation Foundation S, announced the signing of a contract providing support to the ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35 ...